Cytotoxicity of norstictic acid derivatives, a depsidone from Ramalina anceps Nyl.

Structural modifications in lichen phenolic compounds have been one of the tools to potentiate their biological activity. In the present work, seven alkyl derivatives of norstictic acid were prepared and evaluated against eight cell lines. Norstictic acid was isolated from the lichen <i>Ramalina anceps</i> and the alkyl derivatives were obtained through reactions with alcohols. Cytotoxicity was evaluated against the 786-0 (kidney carcinoma), MCF7 (breast carcinoma), HT-29 (colon carcinoma), PC-03 (prostate carcinoma), HEP2 (laryngeal carcinoma), B16-F10 (murine melanoma), UACC-62 (human melanoma), and NIH/3T3 (mouse embryonic fibroblast) cell lines using the sulforhodamine B assay. Norstictic acid exhibited poor activity, while the 8'-<i>O</i>-<i>n</i>-butyl-norstictic acid and 8'-<i>O</i>-<i>sec</i>-butyl-norstictic acid derivatives showed potential activity (GI₅₀ values of 6.37-45.0 μM and 6.8-52.40 μM, respectively) and high selectivity (selectivity index (SI) values of 13.88-98.11 and SI 11.30-87.40, respectively) against all tumor cells. The 8'-<i>O</i>-<i>n</i>-hexyl-norstictic acid showed good activity (5.96-9.53 μM) and moderate selectivity (SI 9.2-5.76) against MCF7, HT-29, PC-03, and HEP2 cells, while 8'-<i>O</i>-isopropyl-norstictic acid demonstrated high activity and selectivity against PC-03 cells (GI₅₀ 1.28 μM and SI 33.8), and was highly active but moderately selective against UACC, HEP2, and B16-F10 cells (GI₅₀ 6.2, 7.78, and 9.65 μM; SI 7.0, 5.5, and 4.5, respectively). Additionally, 8'-<i>O</i>-<i>n</i>-pentyl- and 8'-O-<i>tert</i>-butyl-norstictic acids were active and selective against PC-03 cells (GI₅₀ 8.77 and 7.60 μM; SI 6.53 and 5.0, respectively). Chemometric analysis revealed a clear relationship between all compounds and their biological activities. The insertion of a four-carbon alkyl chain (<i>n</i>-butyl and <i>sec</i>-butyl) produced potentially active compounds on all tested tumor cells.